Caprock Group LLC Invests $1.63 Million in Tenet Healthcare Corporation $THC

Caprock Group LLC bought a new stake in shares of Tenet Healthcare Corporation (NYSE:THC) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 8,042 shares of the company’s stock, valued at approximately $1,633,000.

A number of other hedge funds have also added to or reduced their stakes in the stock. ProShare Advisors LLC lifted its position in shares of Tenet Healthcare by 1.7% in the 2nd quarter. ProShare Advisors LLC now owns 4,118 shares of the company’s stock worth $725,000 after purchasing an additional 67 shares during the period. Quadcap Wealth Management LLC boosted its position in Tenet Healthcare by 1.7% during the 2nd quarter. Quadcap Wealth Management LLC now owns 4,099 shares of the company’s stock valued at $721,000 after acquiring an additional 69 shares in the last quarter. Andina Capital Management LLC grew its holdings in shares of Tenet Healthcare by 2.1% during the 3rd quarter. Andina Capital Management LLC now owns 3,360 shares of the company’s stock worth $682,000 after acquiring an additional 69 shares during the period. Assetmark Inc. lifted its stake in shares of Tenet Healthcare by 0.9% in the 2nd quarter. Assetmark Inc. now owns 8,709 shares of the company’s stock valued at $1,533,000 after purchasing an additional 76 shares during the period. Finally, MGO One Seven LLC boosted its position in shares of Tenet Healthcare by 3.8% during the third quarter. MGO One Seven LLC now owns 2,231 shares of the company’s stock valued at $453,000 after purchasing an additional 82 shares in the last quarter. 95.44% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on THC. Weiss Ratings upgraded shares of Tenet Healthcare from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Monday, December 29th. Royal Bank Of Canada raised their target price on shares of Tenet Healthcare from $253.00 to $277.00 and gave the company an “outperform” rating in a research note on Thursday. Morgan Stanley restated an “overweight” rating and issued a $260.00 price target on shares of Tenet Healthcare in a research note on Thursday. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday. Finally, Cantor Fitzgerald increased their target price on Tenet Healthcare from $190.00 to $245.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 29th. One analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and three have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $242.82.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director Nadja West sold 2,178 shares of the company’s stock in a transaction that occurred on Monday, December 15th. The stock was sold at an average price of $197.47, for a total value of $430,089.66. Following the completion of the transaction, the director directly owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Performance

THC stock opened at $230.90 on Friday. The company has a market cap of $20.29 billion, a P/E ratio of 14.91, a price-to-earnings-growth ratio of 0.97 and a beta of 1.44. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.64. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $235.77. The stock’s fifty day moving average price is $198.82 and its 200-day moving average price is $194.69.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 earnings per share for the quarter, topping the consensus estimate of $4.08 by $0.62. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The business had revenue of $5.53 billion for the quarter, compared to the consensus estimate of $5.47 billion. During the same period last year, the firm earned $3.44 earnings per share. The company’s quarterly revenue was up 8.9% on a year-over-year basis. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. On average, equities analysts forecast that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.